Home » Newsletters » BioWorld Science

BioWorld Science

July 7, 2005

View Archived Issues

New agents for metabolic diseases reported in recent patents

Novel compounds for treatment of glaucoma disclosed in patent literature

Update on sodium oxybate in narcolepsy

Anti-PDGF-D antibody ameliorates mesangioproliferative glomerulonephritis

Therapeutic benefits of Oral-lyn insulin spray in diabetes

Tiagabine improves sleep parameters in patients with primary insomnia

Prous Science announces publication of a comprehensive review on cachexia

NBI-12i: MC4-R antagonist studied for cachexia treatment

Plavix commercial rights transferred in Japan

Second phase III study for GVAX vaccine for prostate cancer

Positive phase I results for VP-025

Preliminary results of phase I study of CRX-675 for ragweed allergy

Novartis again extends tender offer for Eon Labs

New phase I study of satraplatin with Taxotere in solid tumors

Phase I study commences for intranasal parathyroid hormone

New clinical program for intravitreal VEGF Trap for eye diseases

Neumune cleared for U.S. human studies

New indication approved in U.K. for Arimidex

Biotest and Boehringer Ingelheim to investigate BT-061 for asthma

IND approval for cell cycle inhibitor AT-7519

Eyetech selects preclinical candidate in Archemix collaboration

Enhanced clinical benefits of galiximab plus rituximab in follicular non-Hodgkin's lymphoma

Therapeutic benefits of rimonabant in prediabetes and obesity

Megace ES approved for anorexia, cachexia or weight loss in AIDS patients

New MetroGel product approved for rosacea

Orphan drug designations for annamycin in ALL, AML

CB1 receptor antagonist shows promise for osteoporosis treatment

Well-known antifungal drug analyzed for cancer treatment